Pete, although I would love $50B it depends on whe
Post# of 72440
(Total Views: 324)
Posted On: 07/27/2018 10:05:27 AM
Pete, although I would love $50B it depends on when. If we were on the market with Prurisol and revenues were $7B annually and we had 20 years protection then a BP may pay the $50B for a secure cash flow. I still think that is high.
Merck bought Cubist for $8or 9B I believe and they had a run rate of $1B in revenues.
We haven't even entered phase 3. There are no guarantees.
Maybe, maybe the whole company is worth $2-3B right now. Just my guess.
To get the big numbers we will have to partner and ride out the ups and downs.
Merck bought Cubist for $8or 9B I believe and they had a run rate of $1B in revenues.
We haven't even entered phase 3. There are no guarantees.
Maybe, maybe the whole company is worth $2-3B right now. Just my guess.
To get the big numbers we will have to partner and ride out the ups and downs.
(2)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼